Skip to main content
HR 2739 114th Congress House

Cancer Drug Coverage Parity Act of 2015

Official title: To amend the Public Health Service Act to require group and individual health insurance coverage and group health plans to provide for coverage of oral antican… Show full official titleShow less

Official title: To amend the Public Health Service Act to require group and individual health insurance coverage and group health plans to provide for coverage of oral anticancer drugs on terms no less favorable than the coverage provided for anticancer medications administered by a health care provider.

Introduced: June 13, 2016 See on congress.gov
Health CancerDrug therapyHealth care costs and insuranceHealth care coverage and accessPrescription drugs
Sign in to write a letter Sign in to watch
This bill died when the 114th Congress ended
It never became law before the 114th Congress (2015–2016) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 12, 2015
Referred to the Subcommittee on Health.
Jun 11, 2015
Referred to the House Committee on Energy and Commerce.
Jun 11, 2015
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action June 12, 2015

Referred to the Subcommittee on Health.

 Plain-English summary Congressional Research Service

Cancer Drug Coverage Parity Act of 2015

This bill amends the Public Health Service Act to require a group or individual health plan that covers anticancer medications administered by a health care provider to provide no less favorable coverage for anticancer medications administered by a patient. A plan may apply to patient-administered anticancer medications only the cost-sharing and limitations that apply to anticancer medications administered by a health care provider.

These requirements apply to medication approved by the Food and Drug Administration that is prescribed based on a finding by the treating physician that the medication is medically necessary for cancer treatment and is clinically appropriate in terms of type, frequency, extent site, and duration.

To comply with these requirements, health plans may not, for anticancer medications: (1) change or replace benefits to increase out-of-pocket costs; (2) reclassify benefits to increase costs; or (3) apply more restrictive limitations to orally administered medications than to intravenously administered or injected medications.

 Related & companion bills 1
  • S 1566 Identical bill Cancer Drug Coverage Parity Act of 2015
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Cosponsors 55
All 55 Democratic 26 Republican 14
Costello, Ryan
· Sep 26, 2016
 D
Matsui, Doris O.
California · Sep 26, 2016
 D
Frankel, Lois
Florida · Sep 22, 2016
Yoder, Kevin
· Sep 22, 2016
 D
Beatty, Joyce
Ohio · Sep 8, 2016
 R
Kelly, Trent
Mississippi · Sep 8, 2016
 R
Bilirakis, Gus M.
Florida · Sep 7, 2016
 D
Garamendi, John
California · Sep 7, 2016
 D
Peters, Scott H.
California · Sep 7, 2016
 R
Cramer, Kevin
North Dakota · Jul 11, 2016
 D
Davis, Danny K.
Illinois · Jul 11, 2016
Duffy, Sean
· Jul 11, 2016
 D
Himes, James A.
Connecticut · Jul 11, 2016
 D
Lieu, Ted
California · Jun 16, 2016
 D
Boyle, Brendan F.
Pennsylvania · Jun 13, 2016
Donovan, Daniel
· Jun 13, 2016
 R
Hudson, Richard
North Carolina · Jun 13, 2016
 D
Foster, Bill
Illinois · Jun 8, 2016
 R
Guthrie, Brett
Kentucky · May 25, 2016
 D
McGovern, James P.
Massachusetts · May 24, 2016
 R
Latta, Robert E.
Ohio · May 18, 2016
Murphy, Tim
· May 17, 2016
 D
Wasserman Schultz, Debbie
Florida · May 11, 2016
 R
Allen, Rick W.
Georgia · Apr 27, 2016
 R
Blackburn, Marsha
Tennessee · Apr 27, 2016
 D
Bonamici, Suzanne
Oregon · Apr 27, 2016
 R
Griffith, H. Morgan
Virginia · Apr 27, 2016
Harper, Gregg
· Apr 27, 2016
 D
Luján, Ben Ray
New Mexico · Apr 27, 2016
 D
Johnson, Henry C. "Hank"
Georgia · Apr 19, 2016
 D
Pocan, Mark
Wisconsin · Apr 19, 2016
 R
DesJarlais, Scott
Tennessee · Apr 18, 2016
Graves, Tom
· Apr 18, 2016
 R
Sessions, Pete
Texas · Apr 12, 2016
 D
Takano, Mark
California · Apr 12, 2016
WALDEN, GREG
· Apr 12, 2016
 D
Schiff, Adam B.
California · Dec 15, 2015
Comstock, Barbara
· Dec 11, 2015
 R
Carter, Earl L. "Buddy"
Georgia · Dec 1, 2015
 D
Norton, Eleanor Holmes
District of Columbia · Nov 18, 2015
Trott, David
· Sep 30, 2015
 D
DeLauro, Rosa L.
Connecticut · Sep 25, 2015
TIBERI, PATRICK
· Sep 25, 2015
 D
Van Hollen, Chris
Maryland · Sep 9, 2015
Bishop, Mike
· Jul 13, 2015
 D
Pingree, Chellie
Maine · Jul 13, 2015
 D
Tonko, Paul
New York · Jul 9, 2015
 R
Wittman, Robert J.
Virginia · Jul 9, 2015
FRELINGHUYSEN, RODNEY
· Jul 7, 2015
 D
Lofgren, Zoe
California · Jul 7, 2015
Page 1 of 2 Next
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 2739: Cancer Drug Coverage Parity Act of 2015. 114th Congress. Open America. https://openamerica.io/bill/114-HR-2739/
MLA
"H.R. 2739: Cancer Drug Coverage Parity Act of 2015." 114th Congress, 2026, Open America, https://openamerica.io/bill/114-HR-2739/.
Bluebook (legal)
H.R. 2739, 114th Cong. (2026), https://openamerica.io/bill/114-HR-2739/.
Markdown link
[H.R. 2739: Cancer Drug Coverage Parity Act of 2015](https://openamerica.io/bill/114-HR-2739/)
Report a problem